^
No biomarker
Oropharyngeal Cancer
TPF
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
cisplatin + paclitaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
afatinib
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
capecitabine
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
methotrexate
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
5-fluorouracil
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
docetaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
paclitaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
carboplatin
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
pembrolizumab
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
cetuximab
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
cisplatin + docetaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
nivolumab
Sensitive
:
A2
PD-L1 expression
Oropharyngeal Cancer
pembrolizumab
Sensitive
:
C1
No biomarker
Oropharyngeal Cancer
cisplatin + paclitaxel + 5-fluorouracil
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
cisplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
5-fluorouracil + hydroxyurea
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
carboplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
cisplatin
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our